ProCE Banner Activity

Talking With Your Patients About Precision Medicine for Lung and Thyroid Cancers

Clinical Thought
Here are my thoughts on what patients need to know about biomarker testing and targeted therapies for lung and thyroid cancers.

Released: February 23, 2021

Expiration: February 22, 2022

No longer available for credit.

Share

Faculty

Marianne Davies

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP

Associate Professor
Coordinator of Oncology Concentration

Yale University School of Nursing
Oncology Nurse Practitioner
Medical Oncology
Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Lilly

Faculty Disclosure

Primary Author

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP

Associate Professor
Coordinator of Oncology Concentration

Yale University School of Nursing
Oncology Nurse Practitioner
Medical Oncology
Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP, has no relevant conflicts of interest to report.